Skip to main content
Equibles

Nantahala Capital Management, LLC

Position in QURE — uniQure N.V.

CIK 1472322 New Canaan, CT
Back to QURE Full portfolio

Position in QURE

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$3,876,225
-$12,857,976 QoQ
Shares Held
237,078
-66.1% QoQ
Ownership
0.376%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in QURE Over Time

Shares Held

Position Value (USD)

Derivatives in QURE

reported options exposure · as of Mar 31, 2026
CallValue
$42,510,000
CallShares
2,600,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Nantahala Capital Management, LLC holds $599,967,806 across 52 Biotechnology names. QURE ranks #38 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 SLNO
Soleno Therapeutics Inc
 1,744,124 $58,393,271
2 SVRA
Savara Inc
 7,344,783 $40,102,515
3 IMUX
Immunic, Inc.
 2,506,491 $27,822,050
4 TNGX
Tango Therapeutics, Inc.
 1,250,452 $26,159,455
5 LBRX
Lb Pharmaceuticals Inc
 1,052,894 $25,964,366
6 MLYS
Mineralys Therapeutics, Inc.
 895,481 $24,258,580
7 ZVRA
Zevra Therapeutics, Inc.
 2,521,936 $23,504,443
8 FULC
Fulcrum Therapeutics, Inc.
 3,050,040 $23,393,806

All Filings in QURE

Export CSV
46 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,876,225 237,078
2026-03-31 $42,510,000 2,600,000
2025-12-31 $16,734,201 699,298
2025-09-30 $58,807,308 1,007,492
2025-06-30 $28,602,816 2,051,852
2025-03-31 $29,213,197 2,755,962
2024-12-31 $43,326,408 2,453,364
2024-12-31 $3,549,660 201,000
2024-09-30 $990,930 201,000
2024-09-30 $13,710,394 2,781,013
2024-06-30 $11,874,114 2,650,472
2024-06-30 $1,088,640 243,000
2024-03-31 $1,263,600 243,000
2024-03-31 $16,058,026 3,088,082
2023-12-31 $20,025,842 2,958,027
2023-12-31 $1,354,000 200,000
2023-09-30 $20,289,691 3,023,799
2023-09-30 $991,067 147,700
2023-06-30 $32,649,356 2,848,984
2023-06-30 $4,443,042 387,700
2023-03-31 $7,808,278 387,700
2023-03-31 $61,837,070 3,070,361
2022-12-31 $26,925,159 1,187,700
2022-12-31 $61,214,418 2,700,239
2022-09-30 $54,440,188 2,901,929
2022-09-30 $18,760,000 1,000,000
2022-06-30 $57,611,710 3,090,757
2022-06-30 $14,912,000 800,000
2022-03-31 $16,082,300 890,000
2022-03-31 $50,803,064 2,811,459
2021-12-31 $49,015,111 2,363,313
2021-12-31 $43,676,366 2,105,900
2021-09-30 $56,312,568 1,759,218
2021-09-30 $67,409,859 2,105,900
2021-06-30 $54,293,192 1,762,766
2021-06-30 $64,861,720 2,105,900
2021-03-31 $56,359,697 1,672,891
2021-03-31 $50,535,000 1,500,000
2020-12-31 $59,128,154 1,636,539
2020-12-31 $40,194,625 1,112,500
2020-09-30 $58,315,075 1,583,358
2020-09-30 $39,131,875 1,062,500
2020-06-30 $70,660,793 1,568,149
2020-06-30 $47,876,250 1,062,500
2020-03-31 $43,298,125 912,500
2020-03-31 $81,104,956 1,709,272

Report a Problem

Category
Description
Email (optional, for follow-up)